Scott Heysell | OMICS International

Journal of Clinical Infectious Diseases & Practice
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 121

Journal of Clinical Infectious Diseases & Practice received 121 citations as per google scholar report

Journal of Clinical Infectious Diseases & Practice peer review process verified at publons
Indexed In
  • Google Scholar
  • RefSeek
  • Hamdard University
  • Publons
Share This Page

Scott Heysell

Division of Infectious Diseases and International Health, University of Virginia, USA


 Dr. Heysell has field experience in HIV-drug-resistant TB-endemic areas, including rural South Africa (Tugela Ferry), where he lived during post-doctoral training at Yale in tropical infectious diseases. More recently, he has conducted field work in the Kilimanjaro region of Tanzania, where he has consulted at the national drug-resistant TB hospital, Kibong?oto, and has conducted research in partnership with investigators at the Kilimanjaro Clinical Research Institute. Dr. Heysell's research focuses on the understanding of anti-TB pharmacokinetics and the application of novel M. tuberculosis susceptibility testing, particularly in patients with multidrug-resistant TB, or with the co-morbid conditions of HIV or diabetes. He is currently funded by the NIH and non-governmental foundations for projects in Virginia, Tanzania, Bangladesh and Eastern Siberia.

Research Interest

 Multidrug resistant tuberculosis (MDR-TB); pharmacokinetics; clinical application of diagnostics for TB; clinical trials to optimize TB treatment

Global Speakers in the subject

Global Experts in the subject